Is There Scope for Improving the Cost-Effective Prescribing of Nonsteroidal Anti-Inflammatory Drugs?

This publication has 26 references indexed in Scilit:

• The Journal's Policy on Cost-Effectiveness Analyses
  New England Journal of Medicine, 1994
• Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs
  The Lancet, 1994
• A Study of Manufacturer-Supported Trials of Nonsteroidal Anti-inflammatory Drugs in the Treatment of Arthritis
  Archives of internal medicine (1960), 1994
• Duodenal and Gastric Ulcer Prevention with Misoprostol in Arthritis Patients Taking NSAIDs
  Annals of Internal Medicine, 1993
• Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected?
  The Lancet, 1993
• Comparison of an Antiinflammatory Dose of Ibuprofen, an Analgesic Dose of Ibuprofen, and Acetaminophen in the Treatment of Patients with Osteoarthritis of the Knee
  New England Journal of Medicine, 1991
• Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making
  JAMA, 1990
• Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
  Controlled Clinical Trials, 1989
• PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
  The Lancet, 1988
• Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
  BMJ, 1988